Multitargeted molecular docking study of some N-hydroxycinnamamide compounds on ERα, PR, EGFR, and CK2 receptors
Keywords:
belinostat, breast cancer, docking, GOLD 5.3, N-hydroxycinnamamide.Abstract
Breast cancer chemotherapy is marked by targeting the function of receptors such as ERα (estrogen receptor alpha), PR (progesterone receptor), EGFR (epidermal growth factor receptor), and CK2 (protein kinase receptor)...
Downloads
Download data is not yet available.
Downloads
Published
2023-06-25
Issue
Section
KHOA HỌC KỸ THUẬT VÀ CÔNG NGHỆ